
Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
Author(s) -
Citterio Chiara,
Lazzaro Antonio,
Bosi Costanza,
De Ponzio Maurice,
Cavanna Luigi
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4013
Subject(s) - medicine , covid-19 , complication , hematological disorders , hematologic neoplasms , intensive care medicine , cancer , infectious disease (medical specialty) , disease , virology , outbreak
Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.